Rituximab rescues severe PR3-ANCA pulmonary-renal syndrome when standard drugs fail
A case report details how rituximab controlled severe PR3-ANCA pulmonary-renal syndrome in a dialysis-dependent patient after conventional induction therapy failed.
A case report details how rituximab controlled severe PR3-ANCA pulmonary-renal syndrome in a dialysis-dependent patient after conventional induction therapy failed.
A new case report describes a 45-year-old man whose COPA syndrome went undiagnosed for nearly two decades before genetic testing ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine